Small Cap Feast

23rd April 2024

Dish of the day
No Joiners today
Off the menu
No leavers today


Dish Of The Day:


Admissions: 



Delistings: 


Bidstack Group (BIDS.L) has left the AIM market





Whats baking in the oven?

Potential Initial Public Offerings:


Reverse Takeovers:

16 April 2024: Electric Guitar (ELEG.L) Concurrent with its Admission to trading on AIM, Electric Guitar is proposing to acquire the entire issued share capital of 3radical Limited for a consideration of approximately £1.3m, payable by the issue of new ordinary shares in Electric Guitar. The Acquisition constitutes a reverse takeover under the Listing Rules and therefore shareholder approval for the Acquisition is being sought at a general meeting of Electric Guitar to be convened for 1 May 2024.

17 April 2024: TGI Fridays, Inc. (TGIF) Hostmore plc announces that it has reached agreement on a non-binding basis for a proposed all-share acquisition of TGI Fridays, Inc. The Proposed Transaction would result in existing Hostmore shareholders holding 36% of the enlarged business upon completion (the Combined Group), with TGI Fridays shareholders holding a 64% shareholding. TGI Fridays is expected to be purchased for an enterprise value of £177m, or approximately 5.4x its FY23 underlying EBITDA. The Combined Group is expected to be renamed TGI Fridays plc, with its shares admitted to trading on the LSE’s Main Market. Completion of the Proposed Transaction expected to be by the end of Q3 2024.


Change of Market:

8 April 2024: (WRKS.L) a multi-channel value retailers of books, arts and crafts, stationery, toys and games, offering customers a differentiated proposition as a value alternative to full price specialist retailers. The Company is listed on the premium segment of the Main market of the London Stock Exchange. The Company has announced its intention to change to the AIM market on the 3 May 2024.


Banquet Buffet

88 Energy 0.16p £53.0m (88E.L)
The oil and gas exploration and production announces that it proposes to raise up to A$9.8m (approximately £5.23m), within the Company's existing placement capacity, pursuant to a placing of new ordinary shares at a price A$0.003 (equivalent to £0.0016) per share. The Placing Price is equivalent to a discount of 40% to the closing price on the Australian Securities Exchange on 22 April 2024. The net proceeds, together with the Company's existing cash, will strengthen the Company's balance sheet and provide sufficient capital to fund Project Phoenix and Project Leonis in Alaska, as well as PEL 93 in Namibia.

Arecor Therapeutics 132.5p £40.6m (AREC.L)
The biopharmaceutical group advancing today's therapies to enable healthier lives announces that Susan Lowther has decided to step down from her role as Chief Financial Officer, Company Secretary and as a Board Director, to pursue new opportunities. A search for Susan's successor is underway and her last day with Arecor is expected to be on the 22 July, to ensure an effective handover.

Baron Oil 0.068p £17.2m (BOIL.L)
The independent oil and gas exploration and production company provides a update regarding the changes to its Board of Directors and executive positions. John Wakefield has stepped down as Chairman of the Board with effect from 22 April 2024 and Gerry Aherne has now been appointed to the Board as Baron's new Independent Non- Executive Chairman with immediate effect. Jon Ford, Technical Director for Baron, has elected to step down from the Board at the end of April 2024. Jon will be retained by the Company as a part-time technical adviser. Dr John Chessher has joined the Board as an Independent Non-Executive Director with immediate effect. At the executive level, Rob Collins has been appointed as Baron's chief financial officer, currently a non-board position.

Crossword Cybersecurity * 5p £5.1m (CCS.L)
The technology commercialisation company focused on cyber security and risk, announces its final results for the year ended 31 December 2023. Revenue increased 15% to £4.19m (2022: £3.65m), Loss before tax decreased to £4.14m (2022: £4.57m). Cash and cash equivalents decreased to £730k (2022: £2.08m). The Company is targeting strong revenue growth in 2024 and expects its revenue to be within 10% of our anticipated revenue of £7m, albeit at the lower end of the range. Crossword is on track to deliver EBITDA and cash breakeven on a monthly basis during the second half of 2024. A working capital fund raise is anticipated in 2024 to further support the drive to profitability.

Eleco 98.5p £82.0m (ELCO.L)
The specialist software provider for the built environment announces its audited results for the year ended 31 December Total revenue increased 5% to £28.0m (2022: £26.6m). Profit before tax increased 13% to £3.4m (2022: £2.9m). Cash balance decreased to £10.9m (2022: £12.5m) due to M&A activity. As at 31 March 2024, Eleco’s ARR was £24.5m, indicating continued organic growth. Looking forward, the Group is trading in line with 2024 expectations.

Getech Group 8.5p £5.7m (GTC.L)
The locator of subsurface resources announces it has won a new contract with East Star Resources, a London-listed company focused on copper exploration, to locate porphyry copper deposits in Kazakhstan. The project is backed by the BHP Xplor 2024 accelerator programme and is the first time Getech's Globe geoscience platform will be used to locate porphyry copper. The contract win builds on the Company's joint venture agreement with East Star Resources, announced last month, to explore for sedimentary copper deposits in Kazakhstan. For this contract aimed at locating porphyry copper, the Company will receive a fee for exploration services.

itim Group 40p £12.5m (ITIM.L)
The SaaS based technology company that enables store-based retailers to optimise their businesses to improve financial performance, announces that it has signed an additional professional services contract with toy retailer The Entertainer. The Entertainer Toy Shops will be opening in over 800 Tesco stores across the UK and Ireland, extending their partnership following a successful year long trial. The partnership will also see Tesco enter a supplier agreement with The Entertainer for the supermarket's stores across Central Europe. The execution of this contract is in line with the Company's financial expectations for the current financial year.

N4 Pharma 0.85p £2.3m (N4P.L)
The specialist pharmaceutical company developing Nuvec® a novel delivery system for cancer treatments and vaccines, announces its audited results for the year ended 31 December 2023. Loss before tax increased to £1.42m (2022: £1.19m). Cash and cash equivalents decreased t0 £1.03m (2022: £1.92m). Going forward, the Company is consolidating efforts on Nuvec® and actively seeking commercial solutions for the product.

Sareum Holdings * 30.5p £31.0m (SAR.L)
The clinical-stage biotechnology company developing next-generation kinase inhibitors for autoimmune disease and cancer announces that it has issued 2,260,488 new Ordinary Shares to RiverFort Global Opportunities, in accordance with the terms of the Facility announced on 3 August 2023. The issuance of the Riverfort Shares will settle the full outstanding balance on the Riverfort Facility. As noted in Sareum's announcement of 28 March 2024, the Company does not intend to make any further withdrawals pursuant to the Riverfort Facility and accordingly the Company will not be issuing any further Subscription Shares pursuant to the Riverfort Facility.

Watkin Jones 42.725p £109.7m (WJG.L)
The developer and manager of residential-for-rent home announces that, as part of a managed succession process, Sarah Sergeant, Chief Financial Officer, will step down from the Board in mid-June 2024. Simon Jones has been appointed to succeed Sarah. Simon will join Watkin Jones as Chief Financial Officer Designate and as a member of the Board on 21 May 2024 and will work closely with Sarah to ensure a smooth hand over of responsibilities following the publication of the Group's interim results for the six months ended 31 March 2024.

23 April 2024
*A corporate client of Hybridan LLP or retained by Hybridan LLP for certain services
** Arranged by most recent first
*** Alphabetically arranged

STAY INFORMED

Our daily digest of news from UK listed Small and Mid caps straight to your Inbox.

Disclaimer

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.

© Copyright 2024 - Hybridan | Website by Boxed Up Media
First Visit
bookcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram